# For Pediatricians & Specialists: Collaborative Cannabinoid Co-Management (2026) | CĒD Clinic > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/advisor/pediatric-adolescent/autism/for-pediatricians-cannabinoid-co-management/ > **Published:** 2026-09-28T22:24:33-04:00 | **Last Modified / Clinically Audited:** 2026-09-29T00:25:35-04:00 > **Clinical Summary:** CĒD CLINIC Pediatric Autism 🧭 Visual Navigator Symptom Hubs ⚡ Aggression & Meltdowns Acute autonomic de-escalation & safety 🌙 Sleep & Circadian Insomnia Sleep latency, night waking & melatonin 💬 Non-Verbal & Frustration Alternative communication & pain proxies 🍎 Gut-Brain Axis & ARFID Motility, sensory aversions & visceral discomfort 🌪️ Sensory Overload & Stimming Regulating […] --- [CĒD CLINIC Pediatric Autism](https://cedclinic.com/advisor/pediatric-adolescent/autism/) [🧭 Visual Navigator](https://cedclinic.com/advisor/pediatric-adolescent/visual-navigator/) [⚡ Aggression & Meltdowns Acute autonomic de-escalation & safety](https://cedclinic.com/advisor/pediatric-adolescent/autism/aggression-and-meltdowns/) [🌙 Sleep & Circadian Insomnia Sleep latency, night waking & melatonin](https://cedclinic.com/advisor/pediatric-adolescent/autism/sleep-and-insomnia/) [💬 Non-Verbal & Frustration Alternative communication & pain proxies](https://cedclinic.com/advisor/pediatric-adolescent/autism/non-verbal-communication-and-frustration/) [🍎 Gut-Brain Axis & ARFID Motility, sensory aversions & visceral discomfort](https://cedclinic.com/advisor/pediatric-adolescent/autism/gut-brain-axis-and-feeding/) [🌪️ Sensory Overload & Stimming Regulating striatal hyper-reactivity](https://cedclinic.com/advisor/pediatric-adolescent/complex-behavior/) [🧬 Rare Neurogenetic Syndromes Fragile X, SYNGAP1, Rett & CDKL5](https://cedclinic.com/advisor/pediatric-adolescent/genetic-syndromes/) [🌿 Oncology & Palliative Care Pediatric complex care & symptom support](https://cedclinic.com/advisor/pediatric-adolescent/oncology-palliative/) [🎒 Puberty & School Transition Hormonal shifts, IEPs & adolescent care](https://cedclinic.com/advisor/pediatric-adolescent/autism/puberty-adolescence-and-crisis/) Triage & Symptom Screeners [⚖️ Meltdown vs. Seizure Triage Differentiate behavioral storms from subclinical seizures](https://cedclinic.com/advisor/pediatric-adolescent/autism/meltdown-shutdown-seizure-triage/) [🩹 Silent Pain Proxy Checklist Identify hidden physical pain in non-verbal children](https://cedclinic.com/advisor/pediatric-adolescent/autism/silent-pain-somatic-proxy-checklist/) [🦠 Gut vs. Behavior Screener Connect GI reflux/motility to sudden agitation](https://cedclinic.com/advisor/pediatric-adolescent/autism/gut-vs-behavior-screener/) [⚠️ Illness vs. Behavior (PANS) Distinguish infectious flares from neurobehavior](https://cedclinic.com/advisor/pediatric-adolescent/autism/illness-vs-behavior-screener/) [🧠 PDA vs. ODD Screener Demand avoidance rooted in nervous system threat](https://cedclinic.com/advisor/pediatric-adolescent/autism/pda-autism-vs-odd-nervous-system-screener/) Protocols & Care Plans [💊 Medication Interaction Screen CYP450 metabolism & cross-taper safety](https://cedclinic.com/advisor/pediatric-adolescent/autism/medication-interactions/) [🎒 IEP & 504 Accommodations Clinical letter templates for schools](https://cedclinic.com/advisor/pediatric-adolescent/autism/autism-school-iep-504-medical-accommodation-guide/) [🚪 Elopement & Safety Plan First-responder emergency profiles](https://cedclinic.com/advisor/pediatric-adolescent/autism/autism-elopement-wandering-first-responder-safety-plan/) [🕒 Decompression Builder Prevent the 4:00 PM post-school crash](https://cedclinic.com/advisor/pediatric-adolescent/autism/after-school-decompression-builder/) [🛋️ Caregiver Sanctuary Parent nervous system recovery & cortisol balance](https://cedclinic.com/advisor/pediatric-adolescent/autism/caregiver-sanctuary/) [⚖️ Pediatrician & DCF Guide Navigating Mandated Reporting & State Agencies](https://cedclinic.com/advisor/pediatric-adolescent/autism/pediatrician-and-dcf-guide/) [🏛️ Massachusetts Legal Guide Two-physician certification & legal protections](https://cedclinic.com/advisor/pediatric-adolescent/autism/massachusetts-pediatric-medical-cannabis-guide/) [📋 Doctor Discussion Script How to speak with hesitant neurologists & pediatricians](https://cedclinic.com/advisor/pediatric-adolescent/autism/doctor-discussion-guide/) [📁 Clinical Appointment Passport Organized dossier for medical teams](https://cedclinic.com/advisor/pediatric-adolescent/autism/pediatric-autism-clinical-passport-appointment-binder/) [🔬 The Science of Anandamide Endocannabinoid deficiency research in autism](https://cedclinic.com/advisor/pediatric-adolescent/autism/anandamide-and-cannabinoids/) [📅 Book Consult](https://cedclinic.com/book/) [🧭 Open Visual Symptom Navigator](https://cedclinic.com/advisor/pediatric-adolescent/visual-navigator/) Symptom Hubs [⚡ Aggression & Meltdowns](https://cedclinic.com/advisor/pediatric-adolescent/autism/aggression-and-meltdowns/) [🌙 Sleep & Insomnia](https://cedclinic.com/advisor/pediatric-adolescent/autism/sleep-and-insomnia/) [💬 Non-Verbal & Frustration](https://cedclinic.com/advisor/pediatric-adolescent/autism/non-verbal-communication-and-frustration/) [🍎 Gut-Brain & Feeding](https://cedclinic.com/advisor/pediatric-adolescent/autism/gut-brain-axis-and-feeding/) [🌪️ Sensory Overload & Stimming](https://cedclinic.com/advisor/pediatric-adolescent/complex-behavior/) [🧬 Rare Neurogenetic Syndromes](https://cedclinic.com/advisor/pediatric-adolescent/genetic-syndromes/) [🌿 Oncology & Palliative Care](https://cedclinic.com/advisor/pediatric-adolescent/oncology-palliative/) [🎒 Puberty & School Transition](https://cedclinic.com/advisor/pediatric-adolescent/autism/puberty-adolescence-and-crisis/) Clinical Screeners & Tools [⚖️ Meltdown vs. Seizure Triage](https://cedclinic.com/advisor/pediatric-adolescent/autism/meltdown-shutdown-seizure-triage/) [🩹 Silent Pain Proxy Checklist](https://cedclinic.com/advisor/pediatric-adolescent/autism/silent-pain-somatic-proxy-checklist/) [🦠 Gut vs. Behavior Screener](https://cedclinic.com/advisor/pediatric-adolescent/autism/gut-vs-behavior-screener/) [⚠️ Illness vs. Behavior Screener](https://cedclinic.com/advisor/pediatric-adolescent/autism/illness-vs-behavior-screener/) [💊 Medication Interactions](https://cedclinic.com/advisor/pediatric-adolescent/autism/medication-interactions/) [🎒 School IEP & 504 Accommodations](https://cedclinic.com/advisor/pediatric-adolescent/autism/autism-school-iep-504-medical-accommodation-guide/) [🚪 Elopement & Safety Plan](https://cedclinic.com/advisor/pediatric-adolescent/autism/autism-elopement-wandering-first-responder-safety-plan/) [🛋️ Caregiver Sanctuary](https://cedclinic.com/advisor/pediatric-adolescent/autism/caregiver-sanctuary/) Family & Legal Guides [⚖️ Pediatrician & DCF Guide](https://cedclinic.com/advisor/pediatric-adolescent/autism/pediatrician-and-dcf-guide/) [🏛️ Massachusetts Legal Guide](https://cedclinic.com/advisor/pediatric-adolescent/autism/massachusetts-pediatric-medical-cannabis-guide/) [📋 Doctor Discussion Script](https://cedclinic.com/advisor/pediatric-adolescent/autism/doctor-discussion-guide/) [📁 Clinical Passport Binder](https://cedclinic.com/advisor/pediatric-adolescent/autism/pediatric-autism-clinical-passport-appointment-binder/) [📅 Book Consultation with Dr. Caplan](https://cedclinic.com/book/) [Pediatric Care](https://cedclinic.com/pediatrics/) › [Autism Flagship Hub](https://cedclinic.com/advisor/pediatric-adolescent/autism/) › For Pediatricians: Co-Management 🩺 Physician-to-Physician Clinical Collaboration Table of Contents - [For Pediatricians & Specialists: Collaborative Cannabinoid Co-Management](#For_Pediatricians_Specialists_Collaborative_Cannabinoid_Co-Management)[The Institutional Policy Dilemma in Massachusetts Pediatric Medicine](#The_Institutional_Policy_Dilemma_in_Massachusetts_Pediatric_Medicine) - [The Collaborative Division of Responsibilities](#The_Collaborative_Division_of_Responsibilities)[MD-to-MD Direct Peer Consultation Request](#MD-to-MD_Direct_Peer_Consultation_Request) - [Evidence-Based Scientific Foundations & External Guidelines](#Evidence-Based_Scientific_Foundations_External_Guidelines)[Refer a Patient or Schedule an MD Consultation](#Refer_a_Patient_or_Schedule_an_MD_Consultation) # For Pediatricians & Specialists: Collaborative Cannabinoid Co-Management A formal clinical bridge for general pediatricians, pediatric neurologists, child psychiatrists, and developmental specialists seeking safe, evidence-grounded cannabinoid co-management for treatment-refractory neurobehavioral conditions. **Clinical Director:** Dr. Benjamin Caplan, MD (Chief Medical Officer, CĒD Clinic) • **Academic Background:** Former Assistant Professor of Family Medicine, Tufts University School of Medicine • **Published:** September 2026 💡 Key Clinical Takeaway: How Does CĒD Clinic Collaborate with Primary Pediatricians? How does CĒD Clinic interface with a child’s primary care pediatrician and hospital specialists? CĒD Clinic operates strictly as an **adjunctive subspecialty practice**. We do not replace the patient’s primary pediatric medical home, nor do we alter psychiatric or antiepileptic medications independently. We assume complete clinical and legal responsibility for Massachusetts Cannabis Control Commission (CCC) regulatory documentation under **935 CMR 501**, cannabinoid biochemical ratio design (CBD, CBDA, CBG, THC), therapeutic dose titration, CYP450 pharmacokinetic interaction monitoring, and routine hepatic safety surveillance — providing detailed consultation notes back to the primary care provider after every encounter. ## The Institutional Policy Dilemma in Massachusetts Pediatric Medicine Every week, primary pediatricians and specialists across Boston Children’s Hospital, Mass General Brigham, Tufts Children’s Hospital, and UMass Memorial encounter exhausted parents asking about cannabinoid therapeutics for autistic children suffering from self-injurious behavior (SIB), violent meltdowns, or intractable sleep fragmentation. Most physicians face severe institutional barriers: - **Hospital System Prohibitions:** Institutional bylaws at major academic medical centers frequently forbid staff clinicians from formally certifying cannabis due to federal Schedule I status and federal research funding concerns. - **Pharmacology & Dosing Education Gap:** Medical schools and pediatric residency curricula have historically provided zero hours of instruction on the endocannabinoid system ($ECS$), leaving physicians uncomfortable with dosing, ratios, and terpene chemistry. - **CYP450 Liability Concerns:** Legitimate clinical anxiety regarding competitive inhibition of cytochrome P450 enzymes (specifically $CYP3A4$, $CYP2C19$, and $CYP2C9$) when cannabinoids are combined with antiepileptics (Clobazam, Valproate) or antipsychotics (Risperidone, Aripiprazole). **CĒD Clinic solves this institutional dilemma.** We serve as your trusted, board-certified referral partner. You retain full stewardship of the child’s primary medical care, while Dr. Benjamin Caplan oversees the specialized cannabinoid pharmacology and state regulatory compliance. ## The Collaborative Division of Responsibilities Clinical Domain Primary Pediatrician / Specialist CĒD Clinic (Dr. Benjamin Caplan) **Primary Medical Home** Maintains ongoing well-child care, immunizations, diagnostic workups, and primary prescription management. Serves strictly as adjunctive botanical subspecialist; coordinates all changes with the medical home. **935 CMR 501 Certification** Signs the Second Physician Confirmation Form (if permitted by hospital policy) or provides diagnostic progress notes. Performs primary CCC registration, issues physician certification, and manages annual re-evaluations. **Cannabinoid Pharmacokinetics** Informed via detailed CĒD Clinic progress notes of cannabinoid initiation, dosing, and product Certificate of Analysis (COA). Calculates milligram-per-kilogram dosing, selects chemotype ratios (e.g., 20:1 CBD:THC, CBG, CBDA), and audits drug interactions. **Laboratory Surveillance** Collaborates on standard blood panels (CBC, ferritin, metabolic panels). Orders and monitors targeted hepatic transaminases ($ALT/AST$) when high-dose CBD is co-administered with Valproate or Clobazam. Physician Communication Portal ### MD-to-MD Direct Peer Consultation Request Are you a pediatrician, neurologist, or child psychiatrist with questions regarding a complex refractory patient? Connect directly with Dr. Benjamin Caplan for peer-to-peer clinical discussion. Referring Physician Name & Title: Hospital / Practice Affiliation: Specialty: General Pediatrics Pediatric Neurology / Epilepsy Child & Adolescent Psychiatry Developmental-Behavioral Pediatrics Pediatric Gastroenterology Physician Email or Direct Phone: Clinical Question / Patient Summary (De-identified): ✅ **Inquiry Received.** Dr. Benjamin Caplan’s clinical coordinator will contact your office directly within 24 to 48 business hours to schedule a confidential telephone peer consultation. ## Evidence-Based Scientific Foundations & External Guidelines The decision to trial cannabinoid therapeutics in treatment-refractory pediatric autism is grounded in a rapidly expanding corpus of peer-reviewed clinical trials and international registries: - **Randomized Double-Blind Trials:** In a landmark study published in *Neurology* (Aran et al., 2019), whole-plant cannabinoid extracts achieved substantial behavioral disruption improvements in 61% of autistic children, with marked anxiety reduction in 39%. - **National Endocannabinoid Tone Deficits:** Research in *Molecular Autism* (Karhson et al., 2018) demonstrated that circulating concentrations of the endogenous cannabinoid anandamide ($AEA$) are significantly lower in children with ASD compared to neurotypical controls ($p < 0.001$), supporting the clinical hypothesis of an innate endocannabinoid deficiency. - **Safety in Pediatric Epilepsy:** The FDA approval of plant-derived Cannabidiol (Epidiolex) established rigorous pharmacokinetic parameters, demonstrating that cannabinoid therapy is safe when monitored for hepatic enzymes ($ALT/AST$) and serum levels of co-administered antiepileptics. **Helpful External Resources for Clinicians:** • [Massachusetts Cannabis Control Commission (CCC) Regulatory Portal](https://masscannabiscontrol.com/) • [Aran et al., 2019: Cannabinoid Trial in Children with Autism Spectrum Disorder (PubMed)](https://pubmed.ncbi.nlm.nih.gov/30482594/) • [American Academy of Pediatrics (AAP) Pediatric Policy Guidelines](https://www.aap.org/) Physician Collaboration ### Refer a Patient or Schedule an MD Consultation Partner with Dr. Benjamin Caplan to provide your patient's family with safe, legal, and rigorously monitored cannabinoid medicine. We ensure continuous clinical communication with your practice. [Contact Clinical Team →](https://cedclinic.com/book/) --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).